However, the rate and pattern of progression of ... Iommi M, Faragalli A, Bonifazi M, et al. Prognosis and survival in idiopathic pulmonary fibrosis in the era of antifibrotic therapy in Italy ...

PPF is associated with high rates of hospitalization and ... Patient characteristics and survival for progressive pulmonary fibrosis using different definitions. Am J Respir Crit Care Med.

Out-of-hospital cardiac arrest survival rates dropped significantly at the onset of the COVID-19 pandemic in 2020 and have ...

Medscape Medical News, January 16, 2019 High Rate of Complications in 'Real ... 2019 Pirfenidone Improves Idiopathic Pulmonary Fibrosis Survival Pirfenidone increased 3-year survival in patients ...

The death of a much-loved and popular Devon paramedic who devoted nearly 40 years to helping others has inspired his son to ...

The effort by the Center for Regenerative Medicine of Boston University, Boston Medical Center, and GSK aims to find new ...

The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...

A new study by a team of 12 thoracic surgeons at Memorial Sloan Kettering Cancer Center (MSK), published recently in the ...

With new phase 3 data in hand, Boehringer Ingelheim is preparing to file for approval of nerandomilast, a would-be successor to its blockbuster idiopathic pulmonary fibrosis (IPF) therapy Ofev.

The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...